BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 18034870)

  • 1. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome.
    Kim SH; Hu Y; Cadman S; Bouloux P
    J Neuroendocrinol; 2008 Feb; 20(2):141-63. PubMed ID: 18034870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
    Hardelin JP; Dodé C
    Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insights in FGFR1 regulation: lessons from Kallmann syndrome.
    Hu Y; Bouloux PM
    Trends Endocrinol Metab; 2010 Jun; 21(6):385-93. PubMed ID: 20117945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
    Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
    J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-linked GnRH deficiency: role of KAL-1 mutations in GnRH deficiency.
    Hu Y; Bouloux PM
    Mol Cell Endocrinol; 2011 Oct; 346(1-2):13-20. PubMed ID: 21497178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk of anosmin-1, the protein implicated in X-linked Kallmann's syndrome, with heparan sulphate and urokinase-type plasminogen activator.
    Hu Y; González-Martínez D; Kim SH; Bouloux PM
    Biochem J; 2004 Dec; 384(Pt 3):495-505. PubMed ID: 15324302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular genetics of Kallmann syndrome: an update].
    Fu C; Feng Z; Liu RZ
    Zhonghua Nan Ke Xue; 2011 Apr; 17(4):361-5. PubMed ID: 21548217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of disease: Insights into X-linked and autosomal-dominant Kallmann syndrome.
    Tsai PS; Gill JC
    Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):160-71. PubMed ID: 16932275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of hypogonadotropic hypogonadism.
    Bhagavath B; Layman LC
    Semin Reprod Med; 2007 Jul; 25(4):272-86. PubMed ID: 17594608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis of Kallmann's syndrome.
    Cadman SM; Kim SH; Hu Y; González-Martínez D; Bouloux PM
    Horm Res; 2007; 67(5):231-42. PubMed ID: 17191030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [GnRH deficiency: new insights from genetics].
    Kottler ML; Hamel A; Malville E; Richard N
    J Soc Biol; 2004; 198(1):80-7. PubMed ID: 15146960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallmann syndrome.
    Dodé C; Hardelin JP
    Eur J Hum Genet; 2009 Feb; 17(2):139-46. PubMed ID: 18985070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated gonadotropic deficiency with and without anosmia: a developmental defect or a neuroendocrine regulation abnormality of the gonadotropic axis.
    de Roux N
    Horm Res; 2005; 64 Suppl 2():48-55. PubMed ID: 16286771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cysteine-rich region and the whey acidic protein domain are essential for anosmin-1 biological functions.
    Esteban PF; Murcia-Belmonte V; García-González D; de Castro F
    J Neurochem; 2013 Mar; 124(5):708-20. PubMed ID: 23189990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism.
    Versiani BR; Trarbach E; Koenigkam-Santos M; Dos Santos AC; Elias LL; Moreira AC; Latronico AC; de Castro M
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):173-9. PubMed ID: 17223984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2).
    Albuisson J; Pêcheux C; Carel JC; Lacombe D; Leheup B; Lapuzina P; Bouchard P; Legius E; Matthijs G; Wasniewska M; Delpech M; Young J; Hardelin JP; Dodé C
    Hum Mutat; 2005 Jan; 25(1):98-9. PubMed ID: 15605412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anosmin 1 Interacts with the Prokineticin Receptor 2 In Vitro Indicating a Molecular Link Between Both Proteins in the Pathogenesis of Kallmann Syndrome.
    Murcia-Belmonte V; Astillero-López V; Esteban PF
    Protein Pept Lett; 2016; 23(7):650-5. PubMed ID: 27184500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kallmann's syndrome, a neuronal migration defect.
    Cariboni A; Maggi R
    Cell Mol Life Sci; 2006 Nov; 63(21):2512-26. PubMed ID: 16952059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recent genetics of hypogonadotrophic hypogonadism - novel insights and new questions.
    Semple RK; Topaloglu AK
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):427-35. PubMed ID: 19719764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anosmin-1 modulates fibroblast growth factor receptor 1 signaling in human gonadotropin-releasing hormone olfactory neuroblasts through a heparan sulfate-dependent mechanism.
    González-Martínez D; Kim SH; Hu Y; Guimond S; Schofield J; Winyard P; Vannelli GB; Turnbull J; Bouloux PM
    J Neurosci; 2004 Nov; 24(46):10384-92. PubMed ID: 15548653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.